PROSION

PROSION

  • 2022
  • Speaker
  • Venture

A radically new therapeutic approach that aims to improve the quality of life of cancer patients and beyond: PROSION Therapeutics is a biotech & drug development company with a proprietary “LEGO-like” platform, aiming to address highly unmet medical needs by unlocking undruggable protein targets. Starting off in oncology, our mission is to develop new drugs against hard-to-treat diseases with the vision to directly benefit patients’ survival and overall quality of life. As of 2022, PROSION is backed by the European Commission through their prestigious EIC Accelerator.

We use a selection of our own and third-party cookies on the pages of this website: Essential cookies, which are required in order to use the website; functional cookies, which provide better easy of use when using the website; performance cookies, which we use to generate aggregated data on website use and statistics; and marketing cookies, which are used to display relevant content and advertising. If you choose "ACCEPT ALL", you consent to the use of all cookies. You can accept and reject individual cookie types and revoke your consent for the future at any time at "Settings".